Evidence map›Paper›PMID 33815654›Full record

ArticleOxidative medicine and cellular longevity2021

Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis.

Zheng Zha, Yan-Fang Gao, Jing Ji, Ya-Qin Sun, Jun-Ling Li, Fang Qi, Nan Zhang, Liang-Yun Jin, Bing Xue, Tao Yang and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Microglia Polarization: A Novel Target of Exosome for Stroke Treatment.Frontiers in cell and developmental biology · 2022
    Review
  17. Article
  18. Microglia Polarization from M1 toward M2 Phenotype Is Promoted byOxidative medicine and cellular longevity · 2021
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Zheng ZhaSchool of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, China.ORCID https://orcid.org/0000-0001-7497-2441
Yan-Fang GaoSchool of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, China.ORCID https://orcid.org/0000-0002-0433-1929
Jing JiSchool of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, China.ORCID https://orcid.org/0000-0002-4269-3250
Ya-Qin SunSchool of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, China.ORCID https://orcid.org/0000-0001-5404-8470
Jun-Ling LiSchool of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, China.ORCID https://orcid.org/0000-0003-4204-6800
Fang QiSchool of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, China.ORCID https://orcid.org/0000-0002-7941-5289
Nan ZhangSchool of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, China.
Liang-Yun JinCore Facility Center, Capital Medical University, Beijing 100069, China.
Bing XueCore Facility Center, Capital Medical University, Beijing 100069, China.
Tao YangBeijing Tian Tan Hospital, Capital Medical University, Beijing 100070, China.ORCID https://orcid.org/0000-0003-0013-1134
Yong-Ping FanBeijing Tian Tan Hospital, Capital Medical University, Beijing 100070, China.ORCID https://orcid.org/0000-0002-9010-5628
Hui ZhaoSchool of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, China.
Lei WangSchool of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, China.ORCID https://orcid.org/0000-0001-5331-0318
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBu Shen Yi Sui capsule (BSYS) is a traditional Chinese medicine prescription that has shown antineuroinflammatory and neuroprotective effects in treating multiple sclerosis (MS) and its animal model of experimental autoimmune encephalomyelitis (EAE). Microglia play an important role in neuroinflammation. The M1 phenotype of microglia is involved in the proinflammatory process of the disease, while the M2 phenotype plays an anti-inflammatory role. Promoting the polarization of microglia to M2 in MS/EAE is a promising therapeutic strategy. This study is aimed at exploring the effects of BSYS on microglial polarization in mice with EAE.

methodsThe EAE model was established by the intraperitoneal injection of pertussis toxin and subcutaneous injection of myelin oligodendrocyte glycoprotein (MOG)

Indexed as

AnimalsBody WeightBrainCapsulesCCAAT-Enhancer-Binding ProteinsCell DifferentiationCell PolarityCytokinesDemyelinating DiseasesDrugs, Chinese HerbalEncephalomyelitis, Autoimmune, ExperimentalExosomesFemaleInflammationMiceMice, Inbred C57BLbushen yisuiCapsulesCCAAT-Enhancer-Binding ProteinsCEBPA protein, mouseCytokinesDrugs, Chinese HerbalMicroRNAsMirn124 microRNA, mouseMirn155 microRNA, mouseProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Trans-Activators

Identifiers

PMID33815654
PMCPMC7987454
OpenAlexW3137376908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.